Pier Capital »

Halozyme Therapeutics shares owned by Pier Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pier Capital from 13F filings

Historical chart of Pier Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Pier Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Pier Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.8M 130k 36.96
2023-09-30 $5.0M 132k 38.20
2023-06-30 $4.9M 136k 36.07
2023-03-31 $3.4M 88k 38.19
2022-12-31 $9.7M 171k 56.90
2022-09-30 $6.8M 173k 39.54